GlycoCheck™ Related Research:
Infection / COVID-19 /HIV / Dengue
-
Endothelial Glycocalyx Integrity in Treatment-Naive People Living with HIV before and One Year after Antiretroviral Treatment Initiation.
Fragkou PC, Ikonomidis I, Benas D, Kavatha D, Moschopoulos CD, Protopapas K, Kostelli G, Thymis J, Mpirmpa D, Galani I, Tsakona M, Oikonomopoulou C, Theocharous G, Gorgoulis VG, Gallos P, Tsiodras S, Antoniadou A, Papadopoulos A, Triantafyllidi H.Viruses. 2023 Jul 5;15(7):1505
-
Tocilizumab improves oxidative stress and endothelial glycocalyx: A mechanism that may explain the effects of biological treatment on COVID-19
Ikonomidis I, Pavlidis G, Katsimbri P, Lambadiari V, Parissis J, Andreadou I, Tsoumani M, Boumpas D, Kouretas D, Iliodromitis E.Food Chem Toxicol. 2020 Nov;145:111694.
-
Heparanase Is a Putative Mediator of Endothelial Glycocalyx Damage in COVID-19 - A Proof-of-Concept Study.
Drost CC, Rovas A, Osiaevi I, Rauen M, van der Vlag J, Buijsers B, Salmenov R, Lukasz A, Pavenstädt H, Linke WA, Kümpers P.Front Immunol. 2022 Jun 10;13:91651
-
Visual and Biochemical Evidence of Glycocalyx Disruption in Human Dengue Infection, and Association With Plasma Leakage Severity.
Lam PK, McBride A, Le DHT, Huynh TT, Vink H, Wills B, Yacoub S.Front Med (Lausanne). 2020 Oct 16;7:545813..
-
Persistent capillary rarefication in long COVID syndrome.
Osiaevi I, Schulze A, Evers G, Harmening K, Vink H, Kümpers P, Mohr M, Rovas A.Angiogenesis. 2023 Feb;26(1):53-61.
-
Microvascular dysfunction in COVID-19: the MYSTIC study.
Rovas A, Osiaevi I, Buscher K, Sackarnd J, Tepasse PR, Fobker M, Kühn J, Braune S, Göbel U, Thölking G, Gröschel A, Pavenstädt H, Vink H, Kümpers P.Angiogenesis. 2021 Feb;24(1):145-157.